IP Library Granted Patent US 9,452,259
Granted Patent B2
US 9,452,259 · App. 14/063,941 · Granted Sep 27, 2016

Integrated insulin delivery system with continuous glucose sensor

Inventors: John Michael Dobbles (San Clemente, CA); Apurv Ullas Kamath (San Diego, CA); Aarthi Mahalingam (San Diego, CA); James H. Brauker (Addison, MI)
Assignee: DexCom, Inc.
A61M5/1723A61B5/14532A61B5/14546A61M5/14244G06F19/3468A61B5/0031A61M5/003A61M5/178A61M5/30A61M11/00A61M15/00A61M2005/14296A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,452,259
App. No.
14/063,941
Granted
Sep 27, 2016
Kind
B2
Abstract

Systems and methods for integrating a continuous glucose sensor 12 , including a receiver 14 , a medicament delivery device 16 , a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.

Claims (27)

1. A method for diabetes management of a host, the method comprising:

receiving sensor data generated by a continuous glucose monitoring device, wherein the sensor data is indicative of a glucose concentration; tracking and/or evaluating a system error of the continuous glucose monitoring device over time;

determining an insulin therapy instruction, using a controller module of a processor, based on the sensor data and a system error; and

delivering insulin, using an insulin infusion device, to the host based on the insulin therapy instruction from the controller module.

2. The method of claim 1 , wherein the sensor data comprises a possible variation of glucose concentration based on the system error.

3. The method of claim 1 , comprising monitoring an error associated with the system, whereby the system error is determined.

4. The method of claim 3 , comprising iteratively evaluating the determined system error over time and adjusting one or more system parameters based on the iterative evaluation.

5. The method of claim 4 , wherein the one or more system parameters are selected from the group consisting of target range, glucose boundary, bolus constraint, basal profile, rate of insulin delivery, and time of insulin delivery.

6. The method of claim 1 , wherein the system error is associated with the sensor data.

7. The method of claim 1 , wherein determining an insulin therapy instruction is further based on a comparison of the sensor data to a target glucose range, and wherein the target glucose range is adjusted based on the system error.

8. The method of claim 1 , wherein the determining an insulin therapy instruction based on the sensor data and a system error comprises applying the system error as a weighted sum for providing a graded dose adjustment.

9. A system for diabetes management of a host, the system comprising:

a processor comprising a controller module configured to track and/or evaluate a system error of a continuous glucose monitoring device over time, and determine an insulin therapy instruction based on sensor data and the system error, wherein the sensor data is generated by a continuous analyte sensor associated with a glucose concentration of a host; and

an insulin delivery device configured to deliver insulin to the host based on the insulin therapy instruction from the processor.

10. The system of claim 9 , wherein the sensor data comprises a possible variation of glucose concentration based on the system error.

11. The system of claim 9 , wherein the processor is configured to monitor an error associated with the system, whereby the system error is determined.

12. The system of claim 11 , wherein the processor is configured to iteratively evaluate the determined system error over time and to adjust one or more system parameters based on the iterative evaluation.

13. The system of claim 12 , wherein the one or more system parameters are selected from the group consisting of target range, glucose boundary, bolus constraint, basal profile, rate of insulin delivery, and time of insulin delivery.

14. The system of claim 9 , wherein the system error is associated with the sensor data.

15. The system of claim 9 , wherein the controller module is configured to determine an insulin therapy instruction based on a comparison of the sensor data to a target glucose range, and wherein the target glucose range is adjusted based on the system error.

16. The system of claim 9 , wherein the controller module is configured to determine an insulin therapy instruction based on the sensor data and a system error by applying the system error as a weighted sum to provide a graded dose adjustment.

17. The system of claim 9 , further comprising a continuous glucose monitoring device.

18. The system of claim 9 , wherein the continuous glucose monitoring device is configured to monitor an error associated with the system, whereby the system error is determined.

19. A system for diabetes management of a host, the system comprising:

a continuous glucose monitoring device;

a processor comprising a controller module configured to track and/or evaluate a system error of the continuous glucose monitoring device over time, and determine an insulin therapy instruction based on sensor data and the system error, wherein the sensor data is generated by the continuous analyte sensor and is associated with the glucose concentration of the host; and

an insulin delivery device configured to deliver insulin to the host based on the insulin therapy instruction from the processor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2014
From: DOBBLES, MIKE; KAMATH, APURV ULLAS; MAHALINGAM, AARTHI; BRAUKER, JAMES H.
To: DEXCOM, INC.
Reel/Frame 031986/0251 →
Continuity (2)
Continuation 13885604
Related Publication 20140052095A1 · Feb 20, 2014